Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer†.
Saved in:
| Title: | Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer†. |
|---|---|
| Authors: | Falchook, G. S.1, Moulder, S. L.2, Wheler, J. J.1, Jiang, Y.1, Bastida, C. C.1, Kurzrock, R.3 |
| Source: | Annals of Oncology. Dec2013, Vol. 24 Issue 12, p3004-3011. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdt395 |
